Welcome to Rapiscan - A new, easy and safe way to perform pharmacological stress.

Rapiscan is a selective coronary vasodilator for use as a pharmacological stress agent for radionuclide myocardial perfusion imaging (MPI) in adult patients unable to undergo adequate exercise stress.

Rapiscan is the first and only selective A2A adenosine receptor agonist licenced for cardiac functional imaging.

Rapiscan offers a simplified pharmacological stress protocol and is administered as a non-weight based 10-second injection.

Rapiscan is for diagnostic use only.

Stress simplified by design

Rapiscan was discovered and developed specifically to address the needs of nuclear medicine and cardiology by

  • simplifying the pharmacological stress protocol
  • improving tolerability
  • providing an option for patients with asthma and COPD